Company climate footprints leave tracks on private equity returns
In the first months of 2021, when Nordic Capital put EUR 450m on the table to get an ownership share of less than 25% in Danish pharmaceutical firm LEO Pharma, one might have been forgiven for assuming that questions concerning sustainability, CO2 emissions, and leadership diversity were absent from talks.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app